The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Transcriptional regulation of hepatic lipogenesis
Open accessAbstract
Fatty acid and fat synthesis in the liver is a highly regulated metabolic pathway that is important for very low-density lipoprotein (VLDL) production and thus energy distribution to other tissues. Having common features at their promoter regions, lipogenic genes are coordinately regulated at the transcriptional level. Transcription factors, such as upstream stimulatory factors (USFs), sterol regulatory element-binding protein 1C (SREBP1C), liver X receptors (LXRs) and carbohydrate-responsive element-binding protein (ChREBP) have crucial roles in this process. Recently, insights have been gained into the signalling pathways that regulate these transcription factors. After feeding, high blood glucose and insulin levels activate lipogenic genes through several pathways, including the DNA-dependent protein kinase (DNA-PK), atypical protein kinase C (aPKC) and AKT-mTOR pathways. These pathways control the post-translational modifications of transcription factors and co-regulators, such as phosphorylation, acetylation or ubiquitylation, that affect their function, stability and/or localization. Dysregulation of lipogenesis can contribute to hepatosteatosis, which is associated with obesity and insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ChREBP, which is a member of the Mondo family of transcription factors, senses carbohydrates and activates genes involved in glycolysis, DNL, and lipid trafficking [2,34,78].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“DNL is minimal during fasting but increases after a meal as glucose and insulin levels rise, activating insulin signaling via PI3K, AKT, aPKC, mTORC, DNA-dependent protein kinase, and phosphatases [34,83].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“However, it decreased in the presence of severe IR [34,94].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“This result also demonstrates that hepatic steatosis is not necessarily accompanied by IR in DNL in the liver and can be initiated by factors other than insulin signaling [34].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“Thus, insulin activates specific kinases and phosphatases that can modify transcription factors such as upstream stimulatory factor (USF), SREBP1c, ChREBP, and liver X receptor (LXR), or regulate the expression of these transcription factors (Fig. 4) [34,83].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“ChREBP, which is activated by carbohydrate uptake [9,34,78,83].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“In this regard, ChREBP expression in liver biopsies from patients with MASH was observed to be two-fold higher when the histologic steatosis score was greater than 50% compared to those with less than 50%.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“Additionally, substrate-driven pathways as insulin-independent mechanisms contribute to elevated DNL and enhanced esterification of FFAs into hepatic TG [34,70,85,86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [34]
In the citing paper
“VLDL assembly and secretion are upregulated by (i) the delivery of FA released from insulin-resistant adipocytes, (ii) the increased delivery of remnant TG–FA to the liver due to reduced peripheral lipolysis of chylomicron and VLDL–TG, and (iii) the increased de novo lipogenesis55 (Figure 4).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130024 · Cited by 2,401
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. K., Lobaccaro, J. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,724
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P., & Sassone-Corsi, P. (2008) · Cell · doi:10.1016/j.cell.2008.07.002 · Cited by 1,427
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes
Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., & Zhao, K. (2009) · Cell · doi:10.1016/j.cell.2009.06.049 · Cited by 1,344
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,293
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
Cho, H., Zhao, X., Hatori, M., Yu, R. T., Barish, G. D., Lam, M. T., Chong, L.-W., DiTacchio, L., Atkins, A. R., Glass, C. K., et al. (2012) · Nature · doi:10.1038/nature11048 · Cited by 1,037
Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock
Asher, G., & Sassone-Corsi, P. (2015) · Cell · doi:10.1016/j.cell.2015.03.015 · Cited by 844
Cited by
Sorted by citations
Items 101–200 of 648
The Pleiotropic Face of CREB Family Transcription Factors
Chowdhury, M. A. R., An, J., & Jeong, S. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2193 · Cited by 67
Role of HSD17B13 in the liver physiology and pathophysiology
Su, W., Mao, Z., Liu, Y., Zhang, X., Zhang, W., Gustafsson, J.-Α., & Guan, Y. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.014 · Cited by 69
Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
Sunil, B., & Ashraf, A. P. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01336-6 · Cited by 65
Sex differences in growth performance are related to cecal microbiota in chicken
Cui, L., Zhang, X., Cheng, R., Ansari, A. R., Elokil, A., Hu, Y., Chen, Y., Nafady, A. A., & Liu, H. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104710 · Cited by 72
Jin, M., Feng, H., Wang, Y., Yan, S., Shen, B., Li, Z., Qin, H., Wang, Q., Li, J., & Liu, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2940746 · Cited by 65
Self-citationYang, Z., Mi, J., Wang, Y., Xue, L., Liu, J., Fan, M., Zhang, D., Wang, L., Qian, H., & Li, Y. (2021) · Nutrition · doi:10.1016/j.nut.2021.111230 · Cited by 65
Self-citationLuo, H., Ming, J., Lian, G., Liu, Q., Shi, M., Li, T. Y., Song, L., Ye, J., He, Y., Yao, L., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.021 · Cited by 65
Enhanced lipogenesis through Pparγ helps cavefish adapt to food scarcity
Xiong, S., Wang, W., Kenzior, A., Olsen, L. A., Krishnan, J., Persons, J. L., Medley, K., Peuß, R., Wang, Y., Chen, S., et al. (2022) · Current Biology · doi:10.1016/j.cub.2022.03.038 · Cited by 64
Self-citationTang, Z., Sun, C., Yan, Y., Niu, Z., Li, Y., Xu, X., Zhang, J., Wu, Y., Li, Y., Wang, L., et al. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac061 · Cited by 66
The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
Li, S., Xu, Y., Guo, W., Chen, F., Zhang, C., Tan, H. Y., Wang, N., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00351 · Cited by 67
Kim, Y. S., & Kim, S. G. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0173 · Cited by 62
Self-citationAnti-obesity properties and mechanism of action of flavonoids: A review
Oliveira, A. K. D. S., Silva, A. M. D. O. E., Pereira, R. O., Santos, A. S., Barbosa, E. V., Carvalho, M. T. B., Barreto, R. D. S. S., Quintans‐Júnior, L. J., & Quintans, J. D. S. S. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1919051 · Cited by 64
Duan, R., Huang, K., Guan, X., Li, S., Xia, J., Shen, M., Sun, Z., & Yu, Z. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112948 · Cited by 62
Visceral fat: A key mediator of NAFLD development and progression
Bansal, S., Vachher, M., Arora, T. K., Kumar, B., & Burman, A. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200210 · Cited by 69
Ju, U.-I., Jeong, D., Seo, J., Park, J. B., Park, J., Suh, K., Kim, J. B., & Chun, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2472-6 · Cited by 60
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 60
Plasma PFOA and PFOS Levels, DNA Methylation, and Blood Lipid Levels: A Pilot Study
Cheng, X., Wei, Y., Zhang, Z., Wang, F., He, J., Wang, R., Xu, Y., Keerman, M., Zhang, S., Zhang, Y., et al. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c04107 · Cited by 61
Jois, T., Chen, W., HOWARD, V. G., Harvey, R. E., Youngs, K., Thalmann, C., Saha, P., Chan, L., Cowley, M. A., & Sleeman, M. W. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.006 · Cited by 66
The anti-obesogenic effects of dietary berry fruits: A review
Jiang, H., Zhang, W., Li, X., Xü, Y., Cao, J., & Jiang, W. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110539 · Cited by 60
Kodama, T., Yi, J., Newberg, J. Y., Tien, J. C.-Y., Wu, H., Finegold, M. J., Kodama, M., Wei, Z., Tamura, T., Takehara, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808968115 · Cited by 61
The metabolic signature of T cells in rheumatoid arthritis
Weyand, C. M., Wu, B., & Goronzy, J. J. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000683 · Cited by 58
Zhang, J., Ling, N., Yu, L., Peng, M., Hu, P., & Chen, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636897 · Cited by 59
Omar, A. E., Al-Khalaifah, H. S., Osman, A., Gouda, A., Shalaby, S. I., Roushdy, E. M., Abdo, S. A., Ali, S. A., Hassan, A. M., & Amer, S. A. (2022) · Antioxidants · doi:10.3390/antiox11050991 · Cited by 59
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Yang, Z., Danzeng, A., Liu, Q., Zeng, C., Xu, L., Mo, J., Ciren, P., Wang, X., Wang, C., Zhang, B., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87305 · Cited by 61
Endogenous Fatty Acid Synthesis Drives Brown Adipose Tissue Involution
Schlein, C., Fischer, A. W., Sass, F., Worthmann, A., Tödter, K., Jaeckstein, M. Y., Behrens, J. R., Lynes, M. D., Kiebish, M. A., Narain, N. R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108624 · Cited by 60
Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review)
Anggreini, P., Kuncoro, H., Sumiwi, S. A., & Levita, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12922 · Cited by 61
Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ
Lee, J.-B., Yoon, S., Lee, S., Lee, M., Jung, H., Kim, T., Yoon, S. R., Choi, I., Kim, I., Chung, S. W., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0233 · Cited by 58
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 59
Wu, H., Wang, Y., Zhang, B., Li, Y.-L., Ren, Z., Huang, J.-J., Zhang, Z.-Q., Lin, Z., & Zhang, X. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s374439 · Cited by 57
Self-citationLiou, C., Wu, S., Chen, L., Yeh, K., Chen, C., & Huang, W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00589 · Cited by 59
Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis
Liu, Y., Jiang, L., Sun, C., IRELAND, N. M., Shah, Y. M., Liu, Y., & Rui, L. (2018) · Nature Communications · doi:10.1038/s41467-018-05309-y · Cited by 57
Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p
Lan, X., Wu, L., Wu, N., Chen, Q., Li, Y., Du, X., Wei, C., Feng, L., Li, Y., Osoro, E. K., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.018 · Cited by 56
Hormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Tao, Z., & Cheng, Z. (2023) · Clinical Science · doi:10.1042/cs20210519 · Cited by 58
Thyroid hormone action and liver disease, a complex interplay
Marino, L., Kim, A., Ni, B., & Celi, F. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000551 · Cited by 59
Kang, I., Espı́n, J. C., Carr, T. P., Tomás-Barberán, F. A., & Chung, S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.006 · Cited by 57
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
Luo, L., Fang, K., Dan, X., & Gu, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0955-6 · Cited by 56
Rial, S. A., Jutras-Carignan, A., Bergeron, K., & Mounier, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158582 · Cited by 57
De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer
Singh, A., Ruiz, C. F., Bhalla, K., Haley, J. D., Li, Q. K., Acquaah-Mensah, G. K., Montal, E. D., Sudini, K. R., Skoulidis, F., Wistuba, I. I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800204 · Cited by 60
Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells
Huang, W., Chen, Y.-L., Liu, H.-C., Wu, S., & Liou, C. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.07.006 · Cited by 55
Wang, W., Zhang, Z., Wu, Y., Wang, R.-Q., Chen, J., Chen, J., Zhang, Y., Chen, Y.-J., Geng, M., Xu, Z., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00195 · Cited by 55
Familial Combined Hyperlipidemia: Current Knowledge, Perspectives, and Controversies
Bello‐Chavolla, O. Y., Kuri-García, A., Ríos-Ríos, M., Vargas‐Vázquez, A., Cortés-Arroyo, J. E., Tapia-González, G., Cruz‐Bautista, I., & Aguilar-Salinas, C. A. (2018) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.18002575 · Cited by 62
Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats
Liu, H., Zhong, H., Yin, Y., & Jiang, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.130 · Cited by 54
MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1
Wu, G., Rui, C., Chen, J.-Q., Sho, E., Zhan, S., Yuan, X., & Ding, Y.-T. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485765 · Cited by 54
Wang, Y., Yan, S., Xiao, B., Zuo, S., Zhang, Q., Chen, G., Yu, Y., Chen, D., Liu, Q., Liu, Y., et al. (2018) · Diabetes · doi:10.2337/db17-1521 · Cited by 54
Self-citationHCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP
Lane, E. A., Choi, D. W., García-Haro, L., Levine, Z. G., Tedoldi, M., Walker, S., & Danial, N. N. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.019 · Cited by 57
Liou, C., Wu, S., Shen, S., Chen, L., Chen, Y.-L., & Huang, W. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00477-1 · Cited by 54
Nuclear receptor REVERBα is a state-dependent regulator of liver energy metabolism
Hunter, A. L., Pelekanou, C. E., Adamson, A., Downton, P., Barron, N. J., Cornfield, T., Poolman, T. M., Humphreys, N., Cunningham, P. S., Hodson, L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005330117 · Cited by 54
Jadhav, K. S., & Cohen, T. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592157 · Cited by 55
The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism
Fan, Q., Xu, F., Liang, B., & Zou, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.696603 · Cited by 54
Zhu, J., Jin, J., Ding, J., Li, S., Cen, P., Wang, K., Wang, H., & Xia, J. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.05.014 · Cited by 53
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
Yaribeygi, H., Maleki, M., Reiner, Ž., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216544 · Cited by 56
SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1
Zhu, C., Huang, M., Kim, H.-G., Chowdhury, K., Gao, J., Liu, S., Wan, J., Li, W., & Dong, X. C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166249 · Cited by 50
Omega-3 fatty acids mediated Cellular signaling and its regulation in Human Health
Kar, A., Ghosh, P., Patra, P., Chini, D. S., Nath, A. K., Saha, J. K., & Patra, B. C. (2023) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2023.10.004 · Cited by 52
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
Zhou, B., Luo, Y., Bi, H., Zhang, N., Ma, M., Dong, Z., Ji, N., Zhang, S., Wang, X., Liu, Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.014 · Cited by 56
Wu, S., & Näär, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46594-x · Cited by 51
Shabgah, A. G., Norouzi, F., Hedayati‐Moghadam, M., Soleimani, D., Pahlavani, N., & Navashenaq, J. G. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00552-5 · Cited by 49
Wu, Y., Wang, M., Yang, T., Qin, L., Hu, Y.-M., Zhao, D., Wu, L., & Liu, T. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9561613 · Cited by 50
Li, Y., Sun, F., Li, C., Mo, H., Zhou, Y., Lv, D., Zhai, J., Qian, H., & Ma, F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00470-y · Cited by 49
DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions
Medová, M., Medo, M., Hovhannisyan, L., Muñoz-Maldonado, C., Aebersold, D. M., & Zimmer, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107617 · Cited by 48
Séité, S., Harrison, M. C., Sillam‐Dussès, D., Lupoli, R., Dooren, T. J. M. V., Robert, A., Poissonnier, L., Lemainque, A., Renault, D., Acket, S., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02974-6 · Cited by 47
Self-citationHepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice
Chen, Z., Ding, L., Yang, W., Wang, J., Chen, L., Chang, Y., Geng, B., Cui, Q., Guan, Y., & Yang, J. (2017) · Diabetes · doi:10.2337/db16-0993 · Cited by 46
mTOR activation protects liver from ischemia/reperfusion‐induced injury through NF‐κB pathway
Li, Z., Zhang, J., Mulholland, M. T., & Zhang, W. (2017) · The FASEB Journal · doi:10.1096/fj.201601278r · Cited by 48
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
Ma, N., Wang, Y., Xu, S., Ni, Q., Zheng, Q., Zhu, B., Cao, H., Jiang, H., Zhang, F.-K., Yuan, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23285-8 · Cited by 48
Self-citationEffects of In Utero PFOS Exposure on Epigenetics and Metabolism in Mouse Fetal Livers
Ho, T. C., Wan, H. T., Lee, W. K., Lam, T. K. Y., Lin, X., Chan, T., Lai, K. P., & Wong, C. K. C. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c05207 · Cited by 47
Chen, H. (2020) · Liver Research · doi:10.1016/j.livres.2020.02.004 · Cited by 50
Wang, Y., Liu, T., Xie, Y., Li, N., Liu, Y., Wen, J., Zhang, M., Feng, W., Huang, J., Guo, Y., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112008 · Cited by 58
Self-citationKhairnar, R., Islam, M. A., Fleishman, J. S., & Kumar, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121185 · Cited by 49
A multi-tissue metabolome atlas of primate pregnancy
Yu, D., Wan, H., Tong, C., Guang, L., Chen, G., Su, J., Zhang, L., Wang, Y., Xiao, Z., Zhai, J., et al. (2024) · Cell · doi:10.1016/j.cell.2023.11.043 · Cited by 47
Self-citationTazi, A., Araújo, J. R., Mulet, C., Arena, E. T., Nigro, G., Pédron, T., & Sansonetti, P. J. (2018) · mBio · doi:10.1128/mbio.01493-18 · Cited by 46
Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes
Perugini, J., Mercurio, E. D., Tossetta, G., Severi, I., Monaco, F., Reguzzoni, M., Tomasetti, M., Dani, C., Cinti, S., & Giordano, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00768 · Cited by 47
Zhang, X., Wang, Y., Ma, L., Liu, Z.-S., Ye, F., & Yang, J. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0311-z · Cited by 46
Self-citationEffects of soy isoflavone on hepatic steatosis in high fat-induced rats
Liu, H., Zhong, H., Leng, L., & Jiang, Z. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-98 · Cited by 44
Hayasaka, K., Numakura, C., Yamakawa, M., Mitsui, T., Watanabe, H., Haga, H., Yazaki, M., Ohira, H., Ochiai, Y., Tahara, T., et al. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0176-1 · Cited by 43
Circulating microRNAs in human obesity: a systematic review
Ortiz-Dosal, A., Rodil-García, P., & Salazar‐Olivo, L. A. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1606279 · Cited by 44
Brunner, J. S., Vogel, A., Lercher, A., Caldera, M., Korosec, A., Pühringer, M., Hofmann, M., Hajto, A., Kieler, M., Garrido, L. Q., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00311-5 · Cited by 45
Jahandideh, F., & Wu, J. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.001 · Cited by 48
Labaronne, E., Pinteur, C., Véga, N., Pesenti, S., Julien, B., Meugnier, E., Vidal, H., Naville, D., & Magueresse‐Battistoni, B. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.001 · Cited by 43
Adult-onset type II citrullinemia: Current insights and therapy
Hayasaka, K., & Numakura, C. (2018) · The Application of Clinical Genetics · doi:10.2147/tacg.s162084 · Cited by 43
Liver Expressed Antimicrobial Peptide 2 is Associated with Steatosis in Mice and Humans
Ma, X., Xue, X., Zhang, J., Liang, S., Xu, C., Wang, Y., & Zhu, J. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1210-2357 · Cited by 44
Self-citationTomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice
Wu, S., Huang, W., Yu, M., Chen, Y.-L., Shen, S., Yeh, K., & Liou, C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108602 · Cited by 41
Petrovic, A., Igrec, D., Rozac, K., Bojanic, K., Kuna, L., Kolaric, T. O., Mihaljevic, V., Sikora, R., Smolic, R., Glasnovic, M., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060288 · Cited by 41
Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells
Bort, A., Sánchez, B. G., de Miguel, I., Mateos‐Gómez, P. A., & Díaz‐Laviada, I. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05352-3 · Cited by 41
Sajan, M. P., Lee, M. C., Foufelle, F., Sajan, J., Cleland, C., & Farese, R. V. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.12.005 · Cited by 40
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 42
Bagchi, D. P., Li, Z., Corsa, C. A. S., Hardij, J., Mori, H., Learman, B. S., Lewis, K. T., Schill, R. L., Romanelli, S. M., & MacDougald, O. A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100992 · Cited by 38
Chen, C., Zhang, X., Deng, Y., Cui, Q., Zhu, J., Ren, H., Liu, Y., Hu, X., Zuo, J., & Peng, Y. (2020) · FEBS Journal · doi:10.1111/febs.15525 · Cited by 40
Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology
Yerra, V. G., & Drosatos, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054682 · Cited by 37
Peng, Q., Chen, B., Wang, H., Zhu, Y., Wu, J., Luo, Y., Zuo, G., Luo, J., Zhou, L., Shi, Q., et al. (2019) · Aging · doi:10.18632/aging.102552 · Cited by 38
Piceatannol attenuates fat accumulation and oxidative stress in steatosis-induced HepG2 cells
Yang, J. S., Tongson, J., Kim, K., & Park, Y. (2020) · Current Research in Food Science · doi:10.1016/j.crfs.2020.03.008 · Cited by 38
Transcriptional Regulation of Solute Carrier Drug Transporters
Zhou, S., & Shu, Y. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000704 · Cited by 35
Isosilybin regulates lipogenesis and fatty acid oxidation via the AMPK/SREBP-1c/PPARα pathway
Liu, X., Hu, M., Ye, C., Liao, L., Ding, C., Sun, L., Liang, J., & Chen, Y. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110250 · Cited by 41
Zheng, Z., Zhou, Y., Zhang, X., Thu, P. M., Xie, Z., Lu, C., Pang, T., Xue, B., Xu, D., Chen, Y., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.016 · Cited by 41
Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis
Jadeja, R. N., Jones, M. A., Fromal, O., Powell, F. L., Khurana, S., Singh, N., & Martin, P. M. (2019) · Aging · doi:10.18632/aging.101743 · Cited by 39
Chang, Y., & Hung, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114405 · Cited by 38
Siddiqa, A., Cirillo, E., Tareen, S. H. K., Ali, A., Kutmon, M., Eijssen, L., Ahmad, J., Evelo, C. T., & Coort, S. L. (2017) · Genomics · doi:10.1016/j.ygeno.2017.06.006 · Cited by 37
Min, Q.-Q., Qin, L., Sun, Z., Zuo, W.-T., Zhao, L., & Xu, J. (2018) · Nutrients · doi:10.3390/nu10111628 · Cited by 38
Circular RNAs in metabolism and metabolic disorders
Zeng, Y.-Z., Zheng, Z., Liu, F., & Yi, G. (2021) · Obesity Reviews · doi:10.1111/obr.13220 · Cited by 40
Sarmiento-Ortega, V. E., Moroni-González, D., Díaz, A., Brambila, E., & Treviño, S. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-03027-z · Cited by 35
Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL
Ding, L., Huwyler, F., Long, F., Wu, Y., Binz, J., Wernlé, K., Pfister, M., Klug, M., Baláž, M., Ukropcová, B., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01386-y · Cited by 37
Régnier, M., Gourbeyre, P., Pinton, P., Napper, S., Laffitte, J., Cossalter, A., Bailly, J., Lippi, Y., Bertrand‐Michel, J., Bracarense, A. P. F. R. L., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700433 · Cited by 35
Metadata
- Authors
- Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Sul, Hei Sook
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-10-22
- Volume
- 16
- Issue
- 11
- Pages
- 678-689
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC4884795
- OpenAlex
- W2174107467
- Cited by
- 646
- References
- 135
- Citations by year
- 2026: 24 · 2025: 52 · 2024: 60 · 2023: 71 · 2022: 85 · 2021: 74 · 2020: 84 · 2019: 62 · 2018: 67 · 2017: 49 · 2016: 17 · 2015: 1
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-12-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK105671, F32DK105671, R01DK081098, DK081098)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hepatic lipogenesis, transcriptional regulation, upstream stimulatory factor, SREBP-1c, liver X receptor, ChREBP, DNA-dependent protein kinase, atypical protein kinase C, Akt/mTOR signaling, VLDL production, hepatic steatosis, insulin resistance, obesity
- MeSH terms
- Liver X Receptors, Animals, Fatty Acids, Gene Expression Regulation, Lipoproteins, VLDL, Liver, Nuclear Proteins, Protein Kinase C, Protein Processing, Post-Translational, Transcription Factors, Transcription, Genetic, Signal Transduction, Lipogenesis, Proto-Oncogene Proteins c-akt, Mice, Upstream Stimulatory Factors, DNA-Activated Protein Kinase, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Sterol Regulatory Element Binding Protein 1, Orphan Nuclear Receptors, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
